Overview of pyroptosis mechanism and in-depth analysis of cardiomyocyte pyroptosis mediated by NF-κB pathway in heart failure

• Published in: Biomedicine & pharmacotherapy Vol. 179; p. 117367
• Main Authors: Zhang, Zeyu, Yang, Zhihua, Wang, Shuai, Wang, Xianliang, Mao, Jingyuan
• Format: Journal Article
• Language: English
• Published: France Elsevier Masson SAS 01.10.2024; Elsevier
• Subjects: Animals; Cardiomyocytes; Heart failure; Heart Failure - metabolism; Heart Failure - pathology; Humans; Myocytes, Cardiac - metabolism; Myocytes, Cardiac - pathology; NF-kappa B - metabolism; Nuclear factor-κB signaling pathway; Pyroptosis; Pyroptosis - physiology; Signal Transduction; Therapeutic strategies; MLK3; TRAF; RAS; CLP; JNK; Cyt c; HMGB1; LRR; MyD88; TNF; CARD; SHC; NF-κB; OGD/R; STZ; PAMPs; Apaf-1; SpeB; Heart failure; Pyroptosis; GPX4; Pro-IL-1β; PKC; AT1R; DOX; IL-1β; MAPK; MEK; AIM2; ROS; AMPK; Ang; Gzm; NAIP; SIRT; ERK; NTD; Bcl-2; Gβγ; Gα; H/R; CatG; LPS; DAMPs; IκB; ASC; GSK-3β; HMBOX1; GSDM; IRAK 4; NLS; RIPK; NLRP; PYD; RHR; ELANE; TNFR; MLKL; Therapeutic strategies; IKK; Nuclear factor-κB signaling pathway; Cardiomyocytes; AGEs; ICE; RAGE; OGD; LAD; MTOR; CTD; PINK1; TAB; RAF; SOS; MIRI; TAC; Bax; GRB2; MD2; RIP3; RIP1; TAK
• ISSN: 0753-3322; 1950-6007; 1950-6007
• DOI: 10.1016/j.biopha.2024.117367

The pyroptosis of cardiomyocytes has become an essential topic in heart failure research. The abnormal accumulation of these biological factors, including angiotensin II, advanced glycation end products, and various growth factors (such as connective tissue growth factor, vascular endothelial growth factor, transforming growth factor beta, among others), activates the nuclear factor-κB (NF-κB) signaling pathway in cardiovascular diseases, ultimately leading to pyroptosis of cardiomyocytes. Therefore, exploring the underlying molecular biological mechanisms is essential for developing novel drugs and therapeutic strategies. However, our current understanding of the precise regulatory mechanism of this complex signaling pathway in cardiomyocyte pyroptosis is still limited. Given this, this study reviews the milestone discoveries in the field of pyroptosis research since 1986, analyzes in detail the similarities, differences, and interactions between pyroptosis and other cell death modes (such as apoptosis, necroptosis, autophagy, and ferroptosis), and explores the deep connection between pyroptosis and heart failure. At the same time, it depicts in detail the complete pathway of the activation, transmission, and eventual cardiomyocyte pyroptosis of the NF-κB signaling pathway in the process of heart failure. In addition, the study also systematically summarizes various therapeutic approaches that can inhibit NF-κB to reduce cardiomyocyte pyroptosis, including drugs, natural compounds, small molecule inhibitors, gene editing, and other cutting-edge technologies, aiming to provide solid scientific support and new research perspectives for the prevention and treatment of heart failure. [Display omitted] •Pyroptosis of cardiomyocytes is an important pathological change in heart failure.•Activation of the NF-κB pathway promotes pyroptosis of cardiomyocytes, exacerbating heart failure.•Inhibition of the NF-κB pathway represents a novel therapeutic approach for heart failure.